125
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Corporate Capital and (De)Monopolization of Public Health in the USA: An Institutionalist Perspective

References

  • Anderson, Gerard F. 2007. “MarketWatch: From ‘Soak the Rich’ to ‘Soak the Poor’: Recent Trends in Hospital Pricing.” Health Affairs 26 (3): 780–789.
  • Baranes, Avraham Izhar. 2016. “An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets.” PhD diss., University of Missouri-Kansas City.
  • Baranes, Avraham Izhar. 2017. “Financialization in the American Pharmaceutical Industry: A Veblenian Approach.” Journal of Economic Issues 51 (2): 351–358.
  • Blumenthal, David, Elizabeth J. Fowler, Melinda Abrams, and Sara R. Collins. 2020. “COVID-19—Implications for the Health Care System.” New England Journal of Medicine 383 (15): 1483–1488.
  • Centers for Medicare and Medicaid Services (CMS). 2021. “National Health Expenditure Accounts (Historical).” Available from www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsHistorical. Accessed November 10, 2021.
  • Champlin, Dell P., and Janet T. Knoedler. 2008. “Universal Health Care and the Economics of Responsibility.” Journal of Economic Issues 42 (4): 913–938.
  • Chasse, J. Dennis. 1994. “The American Association for Labor Legislation and the Institutionalist Tradition in National Health Insurance.” Journal of Economic Issues 28 (4): 1063–1090.
  • Commons, John R., and John B. Andrews. (1936) 1964. Principles of Labor Legislation. 1936. New York: Augustus M. Kelley.
  • Coughlin, Teresa A. 2014. “Uncompensated Care for the Uninsured in 2013: A Detailed Examination.” Reprint, Kaiser Family Foundation, Menlo Park, CA.
  • Damodaran, Aswath. 2021. The Data Page. Available at people.stern.nyu.edu/adamodar/New_Home_Page/datacurrent.html. Accessed November 10, 2021.
  • Finkelstein, Amy, Neale Mahoney, and Matthew J. Notowidigdo. 2018. “What Does (Formal) Health Insurance Do, and for Whom?” Annual Review of Economics 10 (April): 261–286.
  • Fox, Daniel. 1979. “From Reform to Relativism: A History of Economists and Health Care.” Health and Society 57 (3): 297–336.
  • FRED. 2021. Federal Reserve Economic Data. St. Louis Fed. “Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter,” available at fred.stlouisfed.org/series/QFR120385USNO. “Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Income Retained in Business,” available at fred.stlouisfed.org/series/QFRNIRB385USNO. “Consumer Price Index for All Urban Consumers: Medical Care in U.S. City Average,” available at fred.stlouisfed.org/series/CPIMEDSL. “Consumer Price Index for All Urban Consumers: All Items in U.S. City Average,” available at fred.stlouisfed.org/series/CPIAUCSL. Accessed November 10, 2021.
  • Friesner, Dan. 2009. “Institutional Policy-Making in (In) Action: The Case of Pharmacy Ownership in North Dakota.” Journal of Economic Issues 43 (4): 1025–1042.
  • Ginzberg, Eli. 1974. “The Health Services Industry: Realism in Social Control.” Journal of Economic Issues 8 (2): 381–394.
  • Gonce, Richard A. 2006. “John R. Commons’ Successful Plan for Constitutional, Effective Labor Legislation.” Journal of Economic Issues 40 (4): 1045–1067.
  • Hadley, Jack, John Holahan, Teresa Coughlin, and Dawn Miller. 2008. “Covering the Uninsured in 2008: Current Costs, Sources of Payment, and Incremental Costs.” Health Affairs 27 (S1): w399–w415. doi:https://doi.org/10.1377/hlthaff.27.5.w399.
  • Josifidis, Kosta, and Novica Supic. 2021. “(Are) Institutions More Important Than Innovation?” Journal of Economic Issues 55 (2): 334–341.
  • Keisler-Starkey, Katherine, and Lisa N. Bunch. 2021. U.S. Census Bureau Current Population Reports, P60-274, Health Insurance Coverage in the United States: 2020, U.S. Government Publishing Office, Washington, DC, September 2021.
  • Martin, Anne B., Micah Hartman, David Lassman, and Aaron Catlin. 2021. “National Health Care Spending in 2019: Steady Growth for the Fourth Consecutive Year.” Health Affairs 40 (1): 14–24.
  • Mello-Sampayo, Felipa De, and Sofia De Sousa-Vale. 2014. “Financing Health Care Expenditure in the OECD Countries: Evidence from a Heterogeneous, Cross-Sectional Dependent Panel.” Panoeconomicus 61 (2): 207–225.
  • Mulcahy, Andrew W., Christopher Whaley, Mahlet G. Tebeka, Daniel Schwam, Nathaniel Edenfield, and Alejandro U. Becerra-Ornelas. 2018. “International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies.” Santa Monica, CA: RAND Corporation, 2021. Available at www.rand.org/pubs/research_reports/RR2956.html. Accessed November 10, 2021.
  • OECD. 2021. “Health at a Glance 2021: Facts and Figures.” Available at www.oecd.org/health/health-at-a-glance.htm. Accessed November 18, 2021.
  • Paschall, Stephen. 2008. “John R. Commons’ Contributions to Health Care Reform in the 21st Century.” Journal of Economic Issues 42 (2): 461–468.
  • Paschall, Stephen. 2009. “Health Care, the Price System and the Conflict between Access to Care and Cost-Containment.” Journal of Economic Issues 43 (2): 403–412.
  • Schaniel, William C., and Walter C. Neale. 1999. “Quasi Commodities in the First and Third Worlds.” Journal of Economic Issues 33 (1): 95–115.
  • Scott, Robert H., and Steven Pressman. 2021. “The Not Good Society: Institutional Weaknesses Revealed by COVID-19.” Journal of Economic Issues 55 (2): 477–483.
  • Spithoven, Antoon. 2011. “It’s the Institutions, Stupid! Why U.S. Health Care Expenditure is so Different from Canada’s.” Journal of Economic Issues 45 (1): 75–96.
  • Spithoven, Antoon. 2016. “The Influence of Vested Interests on Healthcare Legislation in the USA, 2009–2010.” Journal of Economic Issues 50 (2): 630–638.
  • Stabile, Donald R. 1993. “Accountants and the Price System: The Problem of Social Costs.” Journal of Economic Issues 27 (1): 171–188.
  • Tulum, Öner, and William Lazonick. 2018. “Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry.” International Journal of Political Economy 47 (3–4): 281–31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.